Home > Insider Trading > Filing (0001127602-21-028140)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
816956	Conmed Corp	CNMD	Electromedical & Electrotherapeutic Apparatus (3845)	160977505

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1627985	Pat Beyer	C/O Conmed Corporation 11311 Concept Boulevard Largo FL 33773	President Int'l & Global Ortho	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-10-29	55,300	$39.87	63,107	No	4	M	Direct
Common Stock	Disposition	2021-10-29	30,018	$144.62	33,089	No	4	F	Direct
Common Stock	Disposition	2021-10-29	2,789	$144.50	30,300	No	4	S	Direct
Common Stock	Disposition	2021-10-29	16,904	$145.31	13,396	No	4	S	Direct
Common Stock	Disposition	2021-10-29	5,589	$146.14	7,807	No	4	S	Direct
Common Stock	Acquisiton	2021-10-29	50,700	$51.30	58,507	No	4	M	Direct
Common Stock	Disposition	2021-10-29	33,253	$146.28	25,254	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options To Purchase Common Stock	Disposition	2021-10-29	55,300	$0.00	55,300	$39.87
Common Stock	Sars (Stock Appreciation Rights)	Disposition	2021-10-29	50,700	$0.00	50,700	$51.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2026-03-01	No	4	M	Direct
0		2025-02-27	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.90 to $144.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.93 to $146.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Plan and generally vest in equal amounts (20%) over a five year period.